HUMA
Humacyte Inc.
Company Overview
| Mkt Cap | $294.57M | Price | $1.67 |
| Volume | 3.26M | Change | +3.09% |
| P/E Ratio | -2.0 | Open | $1.65 |
| Revenue | -- | Prev Close | $1.62 |
| Net Income | $-148.7M | 52W Range | $1.15 - $6.77 |
| Div Yield | N/A | Target | $8.29 |
| Overall | 29 | Value | 40 |
| Quality | -- | Technical | 18 |
No chart data available
Stock Overview
Updated DailyHumacyte Inc. (HUMA) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $1.67 with a market capitalization of $294.57 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows HUMA with a volume of 3.26 million shares. The stock opened up 1.85% from yesterday's close of $1.62. Current analyst estimates project earnings of $-0.68 per share for this year, with next year targeting $-0.52.
HUMA demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for HUMA include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 396.4%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 2, 2025 at 03:28 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HUMA | $1.67 | +3.1% | 3.26M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |